Daewoong Pharmaceutical Co., Ltd.
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 4 name spellings.
8
Ending by 2030
Apr 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 26, 2026The maintenance fee for Method of preparing benzoimidazole derivatives (US 9,040,572) comes due Nov 26, 2026. Unpaid by May 26, 2027, it lapses early.
- 1 fee due Jan 2, 2027The maintenance fee for Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt (US 10,336,695) comes due Jan 2, 2027. Unpaid by Jul 2, 2027, it lapses early.
- 1 fee due Mar 3, 2027The maintenance fee for 4-aminopyrazolo[3,4-d]pyrimidinylazabicyclo derivatives and pharmaceutical composition comprising the same (US 10,399,988) comes due Mar 3, 2027. Unpaid by Sep 3, 2027, it lapses early.
- 1 fee due May 26, 2027The maintenance fee for Acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine (US 10,487,053) comes due May 26, 2027. Unpaid by Nov 26, 2027, it lapses early.
- 2 fees due Jul 2, 2027
- 1 fee due Oct 5, 2027The maintenance fee for Composition comprising tauroursodeoxycholic acid (US 9,301,911) comes due Oct 5, 2027. Unpaid by Apr 5, 2028, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 18, 2026
- 1 term has ended since Aug 18, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,968,579 | Antifungal triazole derivatives In force · From the USPTO record | In force | From the USPTO record | |
| US 8,940,769 | Biaryl benzoimidazole derivatives and pharmaceutical composition comprising the same In force · From the USPTO record | In force | From the USPTO record | |
| US 7,812,045 | Antifungal triazole derivatives In force · From the USPTO record | In force | From the USPTO record | |
| US 9,877,922 | Process of preparing microspheres for sustained release having improved dispersibility and syringeability In force · From the USPTO record | In force | From the USPTO record | |
| US 8,362,012 | Benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and a use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,388,384 | Mesenchymal Stem Cells Produced from Human Pluripotent Stem Cells In force · High confidence | In force | High confidence | |
| US 8,436,022 | Biaryl benzolmidazole derivatives and pharmaceutical composition comprising the same In force · From the USPTO record | In force | From the USPTO record | |
| US 8,026,235 | Pyridyl benzoxazine derivatives, pharmaceutical composition comprising the same, and use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,040,572 | Method of preparing benzoimidazole derivatives In force · From the USPTO record | In force | From the USPTO record | |
| US 9,000,165 | Process for the preparation of anhydrous aripiprazole crystal form II In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 64: 6 patents in force now held by others · 16 lapsed for an unpaid fee · 4 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
18 pending · 2 abandoned · 12 no status recorded